[{"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-001", "question": "A 3-week-old exclusively breastfed infant presents with irritability, poor feeding, and recurrent vomiting. Physical examination reveals a lethargic infant with a bulging fontanelle and opsoclonus-myoclonus syndrome. Laboratory studies show hyponatremia (118 mEq/L), hyperkalemia (6.8 mEq/L), and hypoglycemia (38 mg/dL). Urinary corticosteroid metabolites are markedly elevated. Which genetic mutation is most likely responsible for this infant's presentation?", "options": ["CYP11B1 (11-beta-hydroxylase) mutation", "CYP21A2 (21-hydroxylase) mutation", "StAR (steroidogenic acute regulatory protein) mutation", "CYP17A1 (17-alpha-hydroxylase) mutation", "3β-hydroxysteroid dehydrogenase type 2 mutation"], "answer": "A", "answer_index": 0, "explanation": "This presentation describes the rare 'mineralocorticoid excess' variant of congenital adrenal hyperplasia due to 11-beta-hydroxylase deficiency (CYP11B1 mutation). The key distinguishing features are hypertension and hypokalemia absent despite mineralocorticoid excess symptoms, due to accumulation of deoxycorticosterone. Opsoclonus-myoclonus is an extremely rare but reported presentation. CYP21A2 deficiency typically presents with salt-wasting, not mineralocorticoid excess.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: C (Contradiction). Verdict: No defensible answer. The vignette describes a 3-week-old with hyponatremia (118 mEq/L), hyperkalemia (6.8 mEq/L), and hypoglycemia—classic findings of salt-wasting adrenal insufficiency, most consistent with 21-hydroxylase deficiency (CYP21A2, option B). However, the rationale claims this is 11β-hydroxylase deficiency presenting with 'mineralocorticoid excess,' yet the patient has hyponatremia and hyperkalemia—the opposite of mineralocorticoid excess, which causes hypertension and hypokalemia. This is an internal contradiction: the clinical findings (salt-wasting) directly contradict the stated mechanism (mineralocorticoid excess). The rationale's claim that 'hypertension and hypokalemia [are] absent despite mineralocorticoid excess' is nonsensical—those ARE the defining features of mineralocorticoid excess. Opsoclonus-myoclonus is not a recognized feature of any CAH variant. The electrolyte pattern unequivocally indicates mineralocorticoid deficiency (salt-wasting), making option B the medically correct answer, but the key is A. This represents both a contradiction (C) and miskeying (K), with C being primary. Minimal fix: Rewrite the vignette to show hypertension, hypokalemia, and virilization for 11β-hydroxylase deficiency, or change the key to B for the current presentation.\", \"medical_accuracy_score\": \"1\", \"logical_validity\": false, \"logical_false_reason\": \"C\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: C (Contradiction). Verdict: No defensible answer. The vignette describes a 3-week-old with hyponatremia (118 mEq/L), hyperkalemia (6.8 mEq/L), and hypoglycemia—classic findings of salt-wasting adrenal insufficiency, most consistent with 21-hydroxylase deficiency (CYP21A2, option B). However, the rationale claims this is 11β-hydroxylase deficiency presenting with 'mineralocorticoid excess,' yet the patient has hyponatremia and hyperkalemia—the opposite of mineralocorticoid excess, which causes hypertension and hypokalemia. This is an internal contradiction: the clinical findings (salt-wasting) directly contradict the stated mechanism (mineralocorticoid excess). The rationale's claim that 'hypertension and hypokalemia [are] absent despite mineralocorticoid excess' is nonsensical—those ARE the defining features of mineralocorticoid excess. Opsoclonus-myoclonus is not a recognized feature of any CAH variant. The electrolyte pattern unequivocally indicates mineralocorticoid deficiency (salt-wasting), making option B the medically correct answer, but the key is A. This represents both a contradiction (C) and miskeying (K), with C being primary. Minimal fix: Rewrite the vignette to show hypertension, hypokalemia, and virilization for 11β-hydroxylase deficiency, or change the key to B for the current presentation.", "medical_accuracy_score": 1, "logical_validity": false, "logical_false_reason": "C", "verdict": "FAIL", "fail_reason": "C"}, "judge_verdict": "FAIL", "judge_fail_reason": "C", "judge_medical_accuracy_score": 1}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-002", "question": "A 7-year-old boy with Diamond-Blackfan anemia, maintained on chronic corticosteroid therapy, develops acute respiratory distress. Chest X-ray shows diffuse ground-glass opacities. Bronchoalveolar lavage reveals lipid-laden macrophages positive with Oil Red O staining. The patient has no history of aspiration. Which specific complication of his underlying treatment is most likely responsible?", "options": ["Exogenous lipoid pneumonia from steroid inhaler propellants", "Pulmonary alveolar proteinosis secondary to immunosuppression", "Corticosteroid-induced pulmonary lipomatosis", "Systemic fat embolism from corticosteroid-induced osteonecrosis", "Pulmonary cholesterol ester deposition from dyslipidemia"], "answer": "C", "answer_index": 2, "explanation": "Corticosteroid-induced pulmonary lipomatosis is a rare complication of chronic high-dose steroid therapy characterized by lipid accumulation in pulmonary interstitial macrophages. This differs from aspiration-related lipoid pneumonia as there is no exogenous lipid source. The mechanism involves altered lipid metabolism and macrophage function. Other options represent more common entities but do not fit this specific steroid-related pathology.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict: The keyed answer (C) is not defensible; option D is the most appropriate answer. Key stem clues: 7-year-old on chronic corticosteroids, acute respiratory distress, diffuse ground-glass opacities, lipid-laden macrophages (Oil Red O positive), no aspiration history. The vignette describes lipid-laden macrophages in BAL, which is a nonspecific finding seen in various conditions involving lipid accumulation in alveoli. The keyed answer 'corticosteroid-induced pulmonary lipomatosis' is not a recognized medical entity in standard literature or guidelines. Lipomatosis refers to benign fatty tissue overgrowth, not lipid-laden macrophages in alveoli. Option D (systemic fat embolism from corticosteroid-induced osteonecrosis) is the most defensible answer: chronic corticosteroid use is a well-established risk factor for osteonecrosis/avascular necrosis, which can lead to fat embolism syndrome presenting with respiratory distress, ground-glass opacities, and lipid-laden macrophages. Options A, B, and E are less consistent with the clinical picture. Main medical accuracy issue: The keyed answer invokes a non-existent condition. Minimal fix: Change the correct answer key to D, or rewrite the vignette to describe a recognized steroid complication with this presentation.\", \"medical_accuracy_score\": \"2\", \"logical_validity\": false, \"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: The keyed answer (C) is not defensible; option D is the most appropriate answer. Key stem clues: 7-year-old on chronic corticosteroids, acute respiratory distress, diffuse ground-glass opacities, lipid-laden macrophages (Oil Red O positive), no aspiration history. The vignette describes lipid-laden macrophages in BAL, which is a nonspecific finding seen in various conditions involving lipid accumulation in alveoli. The keyed answer 'corticosteroid-induced pulmonary lipomatosis' is not a recognized medical entity in standard literature or guidelines. Lipomatosis refers to benign fatty tissue overgrowth, not lipid-laden macrophages in alveoli. Option D (systemic fat embolism from corticosteroid-induced osteonecrosis) is the most defensible answer: chronic corticosteroid use is a well-established risk factor for osteonecrosis/avascular necrosis, which can lead to fat embolism syndrome presenting with respiratory distress, ground-glass opacities, and lipid-laden macrophages. Options A, B, and E are less consistent with the clinical picture. Main medical accuracy issue: The keyed answer invokes a non-existent condition. Minimal fix: Change the correct answer key to D, or rewrite the vignette to describe a recognized steroid complication with this presentation.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-003", "question": "A 68-year-old man presents to the ED with acute onset of 'rice-water' diarrhea profuse enough to require intravenous fluid resuscitation. He returned yesterday from a coastal business trip. Stool studies are positive for non-O1, non-O139 Vibrio cholerae. Despite aggressive volume repletion, he develops acute renal failure and profound metabolic acidosis with an anion gap of 28. Which specific toxin-mediated mechanism explains the renal failure pattern?", "options": ["Shiga-like toxin causing hemolytic uremic syndrome", "Heat-stable enterotoxin inducing prerenal azotemia", "RTX toxin causing direct tubular epithelial necrosis", "Zonula occludens toxin leading to ischemic acute tubular necrosis", "Cholera toxin-like effect with profound hypovolemia"], "answer": "C", "answer_index": 2, "explanation": "Non-O1, non-O139 V. cholerae produces RTX (repeats in toxin) toxin which has direct cytotoxic effects on renal tubular epithelium, distinguishing it from classic cholera's pure secretory diarrhea. This explains the development of intrinsic renal failure despite adequate volume repletion. Shiga toxin is produced by enterohemorrhagic E. coli, not Vibrio species. The metabolic acidosis reflects both the diarrhea losses and renal failure.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed – the keyed answer is not the best answer. Key stem clues: 68-year-old with profuse rice-water diarrhea after coastal travel, non-O1/non-O139 V. cholerae, acute renal failure despite aggressive volume repletion, profound metabolic acidosis with anion gap 28. The question asks which toxin-mediated mechanism explains the renal failure pattern. The keyed answer (C: RTX toxin causing direct tubular necrosis) is medically inaccurate. While non-O1/non-O139 V. cholerae can produce RTX toxin, this toxin is primarily associated with wound infections and septicemia, not gastroenteritis-associated renal failure. The clinical presentation describes cholera-like diarrhea (rice-water) with renal failure despite fluid resuscitation. Option E (cholera toxin-like effect with profound hypovolemia) is the most defensible answer, as non-O1/non-O139 strains can produce cholera toxin or similar enterotoxins causing secretory diarrhea. The renal failure likely represents inadequate resuscitation or ongoing losses rather than direct toxin effect. The item conflates RTX toxin's role in extraintestinal disease with gastrointestinal manifestations. Main medical issue: RTX toxin does not cause renal failure in this clinical context. Minimal fix: Change key to E or rewrite vignette to describe wound infection/septicemia rather than gastroenteritis.\", \"medical_accuracy_score\": \"2\", \"logical_validity\": false, \"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed – the keyed answer is not the best answer. Key stem clues: 68-year-old with profuse rice-water diarrhea after coastal travel, non-O1/non-O139 V. cholerae, acute renal failure despite aggressive volume repletion, profound metabolic acidosis with anion gap 28. The question asks which toxin-mediated mechanism explains the renal failure pattern. The keyed answer (C: RTX toxin causing direct tubular necrosis) is medically inaccurate. While non-O1/non-O139 V. cholerae can produce RTX toxin, this toxin is primarily associated with wound infections and septicemia, not gastroenteritis-associated renal failure. The clinical presentation describes cholera-like diarrhea (rice-water) with renal failure despite fluid resuscitation. Option E (cholera toxin-like effect with profound hypovolemia) is the most defensible answer, as non-O1/non-O139 strains can produce cholera toxin or similar enterotoxins causing secretory diarrhea. The renal failure likely represents inadequate resuscitation or ongoing losses rather than direct toxin effect. The item conflates RTX toxin's role in extraintestinal disease with gastrointestinal manifestations. Main medical issue: RTX toxin does not cause renal failure in this clinical context. Minimal fix: Change key to E or rewrite vignette to describe wound infection/septicemia rather than gastroenteritis.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-004", "question": "A 42-year-old woman presents with syncope following several days of fever, myalgias, and diarrhea. ECG shows diffuse ST-segment elevations without reciprocal changes. Echocardiogram reveals a small pericardial effusion with preserved systolic function. Troponin I is elevated at 15 ng/mL. COVID-19 PCR is negative. She recently started doxycycline for suspected Rocky Mountain spotted fever after a camping trip. Which specific pathophysiological mechanism explains this cardiovascular presentation?", "options": ["Direct bacterial invasion of myocardium causing microabscesses", "Immune complex deposition in coronary vasculature", "Rickettsial toxin-mediated coronary vasospasm", "Endothelial damage causing capillary leakage and myocardial edema", "Doxycycline-induced hypersensitivity myocarditis"], "answer": "D", "answer_index": 3, "explanation": "Rickettsial infections cause widespread endothelial damage via intracellular replication, leading to increased vascular permeability. This results in myocardial edema and dysfunction (myopericarditis) rather than discrete infarction. The ST elevations reflect epicardial involvement rather than coronary occlusion. Doxycycline hypersensitivity is possible but unlikely this early in treatment and wouldn't explain the pre-treatment symptoms. Rocky Mountain spotted fever typically causes vasculitis, not vasospasm or immune complex deposition.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: U (Underspecified) leading to M (Multiple answers defensible). Verdict: Not uniquely determinable. The vignette describes a patient with fever, myalgias, diarrhea, syncope, diffuse ST elevations, small pericardial effusion, and elevated troponin after starting doxycycline for suspected RMSF. The clinical problem is identifying the pathophysiological mechanism of this cardiovascular presentation. Key discriminating findings: diffuse ST elevations without reciprocal changes (suggests pericarditis/myopericarditis), elevated troponin (myocardial involvement), preserved systolic function, recent doxicycline initiation. Critical underspecification: The timeline is ambiguous—'recently started doxicycline' and 'several days of fever' don't clarify whether symptoms preceded or followed doxicycline. If symptoms preceded treatment, D (rickettsial endothelial damage) is most defensible. However, if doxicycline was started early in the illness, E (drug-induced hypersensitivity myocarditis) becomes equally plausible, as hypersensitivity can occur within days and presents identically with myopericarditis, elevated troponin, and ST changes. The rationale dismisses E as 'unlikely this early' without defining the timeline. Both D and E can explain the entire presentation. Medical accuracy: The pathophysiology of rickettsial endothelial damage (D) is correct. Minimal fix: Specify exact timeline—'symptoms began 5 days before starting doxicycline 2 days ago' would make D uniquely defensible.\", \"medical_accuracy_score\": \"4\", \"logical_validity\": false, \"logical_false_reason\": \"U\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: U (Underspecified) leading to M (Multiple answers defensible). Verdict: Not uniquely determinable. The vignette describes a patient with fever, myalgias, diarrhea, syncope, diffuse ST elevations, small pericardial effusion, and elevated troponin after starting doxycycline for suspected RMSF. The clinical problem is identifying the pathophysiological mechanism of this cardiovascular presentation. Key discriminating findings: diffuse ST elevations without reciprocal changes (suggests pericarditis/myopericarditis), elevated troponin (myocardial involvement), preserved systolic function, recent doxicycline initiation. Critical underspecification: The timeline is ambiguous—'recently started doxicycline' and 'several days of fever' don't clarify whether symptoms preceded or followed doxicycline. If symptoms preceded treatment, D (rickettsial endothelial damage) is most defensible. However, if doxicycline was started early in the illness, E (drug-induced hypersensitivity myocarditis) becomes equally plausible, as hypersensitivity can occur within days and presents identically with myopericarditis, elevated troponin, and ST changes. The rationale dismisses E as 'unlikely this early' without defining the timeline. Both D and E can explain the entire presentation. Medical accuracy: The pathophysiology of rickettsial endothelial damage (D) is correct. Minimal fix: Specify exact timeline—'symptoms began 5 days before starting doxicycline 2 days ago' would make D uniquely defensible.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-005", "question": "A 24-year-old previously healthy man is brought to the ED after being found unconscious in his apartment. Initial Glasgow Coma Scale is 5. His friend mentions the patient was using 'poppers' recreationally. Arterial blood gas shows methemoglobin level of 25%. Despite methylene blue administration, his mental status does not improve and he requires intubation. CT head shows bilateral globus pallidus infarctions. Which specific toxic mechanism explains the neuroimaging findings?", "options": ["Nitrite-induced vasospasm of lenticulostriate arteries", "Methemoglobinemia causing hypoxic-ischemic injury", "Carbon monoxide contamination of the recreational substance", "Concomitant cyanide poisoning from impurity", "Post-anoxic necrotizing leukoencephalopathy"], "answer": "B", "answer_index": 1, "explanation": "The bilateral globus pallidus infarction pattern is characteristic of hypoxic-ischemic injury, not focal vascular occlusion. While methylene blue treats methemoglobinemia, it cannot reverse established hypoxic brain injury. Nitrite poppers cause methemoglobinemia which reduces oxygen-carrying capacity, leading to global hypoxia that selectively affects vulnerable brain regions like the globus pallidus. This differs from carbon monoxide poisoning which typically affects basal ganglia but through different mechanisms.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes a patient with severe methemoglobinemia (25%) from nitrite poppers presenting with bilateral globus pallidus infarctions. Key clues: GCS 5, poppers use, methemoglobin 25%, bilateral GP infarctions. The question asks for the 'specific toxic mechanism' explaining the neuroimaging. Option B (methemoglobinemia causing hypoxic-ischemic injury) is keyed and medically plausible—methemoglobinemia reduces oxygen-carrying capacity, and GP is vulnerable to hypoxia. However, Option D (concomitant cyanide poisoning) is equally defensible. Alkyl nitrites ('poppers') can contain cyanide impurities, and cyanide classically causes bilateral GP lesions through cytochrome oxidase inhibition, producing histotoxic hypoxia. The stem does not exclude cyanide co-exposure, and the severe presentation (GCS 5, requiring intubation despite methylene blue) could suggest additional toxicity beyond methemoglobinemia alone. The rationale dismisses other options but doesn't address why cyanide is excluded. Medical accuracy: Both mechanisms are valid for GP injury. Main issue: The stem is underspecified regarding cyanide testing/exclusion, creating ambiguity between B and D. Minimal fix: Add 'cyanide level undetectable' or specify 'methemoglobinemia alone' to eliminate D as a contender.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes a patient with severe methemoglobinemia (25%) from nitrite poppers presenting with bilateral globus pallidus infarctions. Key clues: GCS 5, poppers use, methemoglobin 25%, bilateral GP infarctions. The question asks for the 'specific toxic mechanism' explaining the neuroimaging. Option B (methemoglobinemia causing hypoxic-ischemic injury) is keyed and medically plausible—methemoglobinemia reduces oxygen-carrying capacity, and GP is vulnerable to hypoxia. However, Option D (concomitant cyanide poisoning) is equally defensible. Alkyl nitrites ('poppers') can contain cyanide impurities, and cyanide classically causes bilateral GP lesions through cytochrome oxidase inhibition, producing histotoxic hypoxia. The stem does not exclude cyanide co-exposure, and the severe presentation (GCS 5, requiring intubation despite methylene blue) could suggest additional toxicity beyond methemoglobinemia alone. The rationale dismisses other options but doesn't address why cyanide is excluded. Medical accuracy: Both mechanisms are valid for GP injury. Main issue: The stem is underspecified regarding cyanide testing/exclusion, creating ambiguity between B and D. Minimal fix: Add 'cyanide level undetectable' or specify 'methemoglobinemia alone' to eliminate D as a contender.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-006", "question": "A 34-year-old G1P0 at 28 weeks gestation presents with acute abdominal pain and hypertension (160/100 mmHg). Ultrasound reveals a viable fetus with oligohydramnios and placental lakes. MRI demonstrates complete placental separation with a 'dark intraplacental band' on T2-weighted imaging. Laboratory studies show elevated AST/ALT (250/280 U/L) and low platelets (85,000/μL). Despite magnesium sulfate infusion, she develops seizures. Which specific placental pathology is confirmed by the MRI finding?", "options": ["Placental abruption with Couvelaire uterus", "Placenta accreta spectrum disorder", "Migratory placental thrombophilia", "Massive perivillous fibrin deposition", "Placental infarction from spiral artery thrombosis"], "answer": "A", "answer_index": 0, "explanation": "The 'dark intraplacental band' on T2-weighted MRI is pathognomonic for retroplacental hematoma in abruption. This case represents severe preeclampsia progressing to eclampsia with HELLP syndrome and abruption. Couvelaire uterus refers to blood infiltrating the myometrium, which can be seen with abruption. The other options describe different placental pathologies that would not typically present with this acute hypertensive picture or the specific MRI finding.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes severe preeclampsia/eclampsia with HELLP syndrome (hypertension, seizures despite magnesium, elevated transaminases, thrombocytopenia) and placental abruption (acute pain, complete placental separation, retroplacental hematoma). The question asks which pathology is 'confirmed by the MRI finding' of a dark intraplacental band. Option A (abruption with Couvelaire uterus) is defensible because the MRI finding confirms abruption, and Couvelaire uterus can accompany severe abruption. However, Option A is problematic because: (1) the dark band confirms retroplacental hematoma/abruption itself, not specifically Couvelaire uterus (myometrial blood infiltration), which would require different MRI findings; (2) the question stem already states 'complete placental separation,' making abruption clinically obvious before considering the MRI band. If the MRI finding specifically confirms abruption (not Couvelaire), then simple 'placental abruption' would be the answer, but that's not offered. The other options are clearly incorrect for this acute presentation. Main issue: the stem pre-establishes abruption, then asks what the MRI 'confirms'—creating ambiguity about whether it's confirming abruption itself or the Couvelaire component. Minimal fix: Rephrase to ask 'What does the dark intraplacental band on MRI represent?' or offer 'Placental abruption' without the Couvelaire qualifier.\", \"medical_accuracy_score\": \"3\", \"logical_validity\": false, \"logical_false_reason\": \"U\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes severe preeclampsia/eclampsia with HELLP syndrome (hypertension, seizures despite magnesium, elevated transaminases, thrombocytopenia) and placental abruption (acute pain, complete placental separation, retroplacental hematoma). The question asks which pathology is 'confirmed by the MRI finding' of a dark intraplacental band. Option A (abruption with Couvelaire uterus) is defensible because the MRI finding confirms abruption, and Couvelaire uterus can accompany severe abruption. However, Option A is problematic because: (1) the dark band confirms retroplacental hematoma/abruption itself, not specifically Couvelaire uterus (myometrial blood infiltration), which would require different MRI findings; (2) the question stem already states 'complete placental separation,' making abruption clinically obvious before considering the MRI band. If the MRI finding specifically confirms abruption (not Couvelaire), then simple 'placental abruption' would be the answer, but that's not offered. The other options are clearly incorrect for this acute presentation. Main issue: the stem pre-establishes abruption, then asks what the MRI 'confirms'—creating ambiguity about whether it's confirming abruption itself or the Couvelaire component. Minimal fix: Rephrase to ask 'What does the dark intraplacental band on MRI represent?' or offer 'Placental abruption' without the Couvelaire qualifier.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "U", "verdict": "FAIL", "fail_reason": "U"}, "judge_verdict": "FAIL", "judge_fail_reason": "U", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-007", "question": "A 62-year-old man with esophageal cancer presents for esophagectomy. During one-lung ventilation, his oxygen saturation drops to 82%. The anesthesia team notes increased airway pressures and frothy pink secretions from the endotracheal tube. Transesophageal echocardiography shows new right ventricular dilatation with septal flattening. Despite 100% FiO2 and PEEP, hypoxia persists. Administration of which specific medication is most likely to improve oxygenation in this scenario?", "options": ["Alprostadil (prostaglandin E1)", "Inhaled epoprostenol (prostacyclin)", "Intravenous milrinone", "Inhaled nitric oxide", "Intravenous phenylephrine"], "answer": "B", "answer_index": 1, "explanation": "This scenario describes acute right ventricular failure and hypoxia during one-lung ventilation, likely due to increased pulmonary vascular resistance. Inhaled epoprostenol selectively vasodilates the ventilated lung, improving V/Q matching without systemic hypotension. Inhaled nitric oxide has similar effects but is more expensive and less readily available. Milrinone causes systemic vasodilation which could worsen hypotension. Phenylephrine would increase afterload on the failing right ventricle. Alprostadil is used for ductal patency, not acute RV failure.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes acute RV failure with hypoxia during one-lung ventilation, evidenced by RV dilatation, septal flattening, increased airway pressures, and frothy secretions suggesting pulmonary edema. Key discriminating findings point to acute pulmonary hypertension/RV failure. The question asks which medication will \\\"most likely improve oxygenation.\\\" Both inhaled epoprostenol (B, keyed) and inhaled nitric oxide (D) are selective pulmonary vasodilators that improve V/Q matching by dilating vessels in ventilated lung regions without causing systemic hypotension. The rationale acknowledges they have \\\"similar effects\\\" but dismisses nitric oxide based on cost/availability—factors external to clinical efficacy. In a board exam testing medical knowledge, the \\\"most likely to improve oxygenation\\\" should be determined by pharmacologic mechanism and clinical efficacy, not availability. Both agents are equally defensible as best answers for improving oxygenation in this scenario. Options A, C, and E are appropriately eliminated (wrong indication, systemic effects, increased RV afterload). Main logical issue: Two options with equivalent therapeutic mechanisms for the stated goal. Main medical accuracy issue: Rationale uses non-clinical criteria to differentiate equivalent therapies. Minimal fix: Specify \\\"most readily available\\\" or provide clinical context favoring one agent, or accept either B or D as correct.\",\"medical_accuracy_score\":\"4\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes acute RV failure with hypoxia during one-lung ventilation, evidenced by RV dilatation, septal flattening, increased airway pressures, and frothy secretions suggesting pulmonary edema. Key discriminating findings point to acute pulmonary hypertension/RV failure. The question asks which medication will \"most likely improve oxygenation.\" Both inhaled epoprostenol (B, keyed) and inhaled nitric oxide (D) are selective pulmonary vasodilators that improve V/Q matching by dilating vessels in ventilated lung regions without causing systemic hypotension. The rationale acknowledges they have \"similar effects\" but dismisses nitric oxide based on cost/availability—factors external to clinical efficacy. In a board exam testing medical knowledge, the \"most likely to improve oxygenation\" should be determined by pharmacologic mechanism and clinical efficacy, not availability. Both agents are equally defensible as best answers for improving oxygenation in this scenario. Options A, C, and E are appropriately eliminated (wrong indication, systemic effects, increased RV afterload). Main logical issue: Two options with equivalent therapeutic mechanisms for the stated goal. Main medical accuracy issue: Rationale uses non-clinical criteria to differentiate equivalent therapies. Minimal fix: Specify \"most readily available\" or provide clinical context favoring one agent, or accept either B or D as correct.", "medical_accuracy_score": 4, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 4}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-008", "question": "A 45-year-old woman with metastatic carcinoid syndrome presents for emergent small bowel obstruction surgery. During anesthesia induction, she develops profound hypotension refractory to fluid boluses and phenylephrine. ECG shows sinus tachycardia with non-specific ST changes. Transesophageal echocardiography reveals global hypokinesis with apical sparing ('takotsubo-like' pattern). Which specific pharmacologic intervention is most appropriate?", "options": ["Intravenous octreotide", "Intravenous corticosteroids", "Intravenous β-blocker", "Intravenous calcium gluconate", "Intravenous methylene blue"], "answer": "A", "answer_index": 0, "explanation": "This describes carcinoid crisis mediated by massive serotonin release, causing both hypotension and catecholamine-mediated myocardial stunning (carcinoid heart disease). Octreotide is the specific antidote that inhibits serotonin release. β-blockers could worsen hypotension and bronchospasm. Corticosteroids might help with refractory shock but are not specific. Calcium and methylene blue have no role in carcinoid crisis management. The apical sparing pattern reflects catecholamine-mediated stunning rather than primary cardiac ischemia.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The vignette describes a patient with metastatic carcinoid syndrome developing intraoperative hypotension refractory to fluids and phenylephrine, with TEE showing a takotsubo-like pattern. Key stem clues: carcinoid syndrome, perioperative setting, refractory hypotension, and global hypokinesis with apical sparing. The question conflates two distinct clinical entities: (1) carcinoid crisis (treated with octreotide) and (2) takotsubo cardiomyopathy/catecholamine-mediated stunning (supportive care, sometimes beta-blockers once stabilized). The rationale claims the takotsubo pattern is from 'carcinoid heart disease,' but carcinoid heart disease typically causes right-sided valvular fibrosis, not acute LV dysfunction with apical sparing. The takotsubo pattern suggests catecholamine surge, which could occur during carcinoid crisis but represents a distinct pathophysiology. While octreotide (A) is standard for carcinoid crisis, the prominent takotsubo pattern raises whether addressing the myocardial stunning component is equally or more urgent. Beta-blockers (C) are contraindicated acutely in hypotensive takotsubo but might be considered after stabilization. The stem doesn't clearly establish whether serotonin excess or catecholamine-mediated stunning is the dominant problem requiring immediate intervention. Minimal fix: Clarify whether flushing, bronchospasm, or other carcinoid crisis features are present to make octreotide unambiguously best.\", \"medical_accuracy_score\": \"3\", \"logical_validity\": false, \"logical_false_reason\": \"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The vignette describes a patient with metastatic carcinoid syndrome developing intraoperative hypotension refractory to fluids and phenylephrine, with TEE showing a takotsubo-like pattern. Key stem clues: carcinoid syndrome, perioperative setting, refractory hypotension, and global hypokinesis with apical sparing. The question conflates two distinct clinical entities: (1) carcinoid crisis (treated with octreotide) and (2) takotsubo cardiomyopathy/catecholamine-mediated stunning (supportive care, sometimes beta-blockers once stabilized). The rationale claims the takotsubo pattern is from 'carcinoid heart disease,' but carcinoid heart disease typically causes right-sided valvular fibrosis, not acute LV dysfunction with apical sparing. The takotsubo pattern suggests catecholamine surge, which could occur during carcinoid crisis but represents a distinct pathophysiology. While octreotide (A) is standard for carcinoid crisis, the prominent takotsubo pattern raises whether addressing the myocardial stunning component is equally or more urgent. Beta-blockers (C) are contraindicated acutely in hypotensive takotsubo but might be considered after stabilization. The stem doesn't clearly establish whether serotonin excess or catecholamine-mediated stunning is the dominant problem requiring immediate intervention. Minimal fix: Clarify whether flushing, bronchospasm, or other carcinoid crisis features are present to make octreotide unambiguously best.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-009", "question": "A 28-year-old graduate student presents with 6 months of progressive social withdrawal, odd rituals involving numbers, and vague somatic complaints. He believes his thoughts are being broadcast to others. His speech is tangential with occasional neologisms. Neuropsychological testing shows preserved memory but significant executive dysfunction. MRI brain is normal. Which specific clinical feature most strongly predicts poor response to antipsychotic medication?", "options": ["Poor premorbid social functioning", "Prominent negative symptoms", "Executive dysfunction out of proportion to other deficits", "Later age of onset", "Presence of Schneiderian first-rank symptoms"], "answer": "C", "answer_index": 2, "explanation": "Executive dysfunction that is disproportionately severe compared to other cognitive domains is a hallmark of deficit syndrome schizophrenia, which predicts poor medication response. While negative symptoms and poor premorbid functioning are also poor prognostic factors, the specific pattern of executive dysfunction is the strongest predictor among these options. Later age of onset and first-rank symptoms are generally associated with better prognosis in schizophrenia spectrum disorders.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The vignette describes a 28-year-old with psychotic symptoms (thought broadcasting, tangential speech, neologisms) and neuropsychological findings showing preserved memory but significant executive dysfunction. The question asks which feature \\\"most strongly predicts poor response to antipsychotic medication.\\\" Key issue: The stem presents executive dysfunction as a finding, but option C requires it to be \\\"out of proportion to other deficits\\\"—a distinction not clearly established since only memory is mentioned as preserved. More critically, options B (prominent negative symptoms) and C both predict poor antipsychotic response with comparable evidence strength. The rationale claims executive dysfunction is the \\\"strongest predictor,\\\" but prominent negative symptoms (social withdrawal, odd rituals suggesting deficit syndrome) are equally well-established predictors of poor treatment response in schizophrenia literature. Option A (poor premorbid functioning) is also a robust predictor. The stem lacks sufficient detail to discriminate among these three poor-prognosis factors. Medical accuracy is reasonable (score 3-4) but the logical structure allows multiple defensible answers. Minimal fix: Specify baseline cognitive testing showing selective executive impairment with intact other domains, or reframe to ask about cognitive predictors specifically.\", \"medical_accuracy_score\": \"3\", \"logical_validity\": false, \"logical_false_reason\": \"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The vignette describes a 28-year-old with psychotic symptoms (thought broadcasting, tangential speech, neologisms) and neuropsychological findings showing preserved memory but significant executive dysfunction. The question asks which feature \"most strongly predicts poor response to antipsychotic medication.\" Key issue: The stem presents executive dysfunction as a finding, but option C requires it to be \"out of proportion to other deficits\"—a distinction not clearly established since only memory is mentioned as preserved. More critically, options B (prominent negative symptoms) and C both predict poor antipsychotic response with comparable evidence strength. The rationale claims executive dysfunction is the \"strongest predictor,\" but prominent negative symptoms (social withdrawal, odd rituals suggesting deficit syndrome) are equally well-established predictors of poor treatment response in schizophrenia literature. Option A (poor premorbid functioning) is also a robust predictor. The stem lacks sufficient detail to discriminate among these three poor-prognosis factors. Medical accuracy is reasonable (score 3-4) but the logical structure allows multiple defensible answers. Minimal fix: Specify baseline cognitive testing showing selective executive impairment with intact other domains, or reframe to ask about cognitive predictors specifically.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-010", "question": "A 55-year-old woman with treatment-resistant depression develops progressive cerebellar ataxia, nystagmus, and peripheral neuropathy over 6 months. Brain MRI shows symmetric T2 hyperintensities in the dentate nuclei. She has been on lithium for 15 years with therapeutic levels. Which specific underlying neurodegenerative disorder is suggested by this neurological presentation?", "options": ["Multiple system atrophy-cerebellar type", "Spinocerebellar ataxia type 3", "Cerebrotendinous xanthomatosis", "Gerstmann-Sträussler-Scheinker disease", "Adult-onset Niemann-Pick disease type C"], "answer": "E", "answer_index": 4, "explanation": "Adult-onset Niemann-Pick type C often presents with psychiatric symptoms (including depression or psychosis) years before neurological manifestations. The combination of vertical supranuclear gaze palsy, cerebellar ataxia, and neuropsychiatric features is characteristic. Lithium may unmask or accelerate the presentation. The other options do not typically present with this combination of psychiatric prodrome and specific neurological findings. Cerebrotendinous xanthomatosis causes tendon xanthomas and diarrhea, not typically psychiatric symptoms.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer does not match the clinical presentation. Key stem clues: 15-year lithium use with therapeutic levels, progressive cerebellar ataxia, nystagmus, peripheral neuropathy, symmetric T2 hyperintensities in dentate nuclei. The vignette describes classic chronic lithium neurotoxicity (SILENT syndrome - Syndrome of Irreversible Lithium-Effectuated Neurotoxicity), not a primary neurodegenerative disorder. The MRI finding of symmetric dentate nuclei T2 hyperintensities is pathognomonic for lithium toxicity. Main logical issue: The question asks for an \\\"underlying neurodegenerative disorder,\\\" but the presentation is iatrogenic lithium toxicity, not a primary degenerative disease. The keyed answer (E) is incorrect because: (1) Niemann-Pick C characteristically presents with vertical supranuclear gaze palsy (not mentioned), hepatosplenomegaly, and different MRI patterns; (2) the rationale mentions vertical gaze palsy as characteristic, but this finding is absent from the vignette; (3) the psychiatric symptoms preceded lithium use by definition. Main medical accuracy issue: The item conflates lithium toxicity with primary neurodegeneration. Minimal fix: Either remove lithium history and add vertical gaze palsy to support answer E, or change the question to ask about the cause of the neurological syndrome (answer: lithium toxicity).\", \"medical_accuracy_score\": \"2\", \"logical_validity\": false, \"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer does not match the clinical presentation. Key stem clues: 15-year lithium use with therapeutic levels, progressive cerebellar ataxia, nystagmus, peripheral neuropathy, symmetric T2 hyperintensities in dentate nuclei. The vignette describes classic chronic lithium neurotoxicity (SILENT syndrome - Syndrome of Irreversible Lithium-Effectuated Neurotoxicity), not a primary neurodegenerative disorder. The MRI finding of symmetric dentate nuclei T2 hyperintensities is pathognomonic for lithium toxicity. Main logical issue: The question asks for an \"underlying neurodegenerative disorder,\" but the presentation is iatrogenic lithium toxicity, not a primary degenerative disease. The keyed answer (E) is incorrect because: (1) Niemann-Pick C characteristically presents with vertical supranuclear gaze palsy (not mentioned), hepatosplenomegaly, and different MRI patterns; (2) the rationale mentions vertical gaze palsy as characteristic, but this finding is absent from the vignette; (3) the psychiatric symptoms preceded lithium use by definition. Main medical accuracy issue: The item conflates lithium toxicity with primary neurodegeneration. Minimal fix: Either remove lithium history and add vertical gaze palsy to support answer E, or change the question to ask about the cause of the neurological syndrome (answer: lithium toxicity).", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-011", "question": "A 2-month-old infant presents with failure to thrive, vomiting, and hypothermia. Laboratory studies reveal hyponatremia (120 mEq/L), hyperkalemia (6.5 mEq/L), and metabolic acidosis. Newborn screening was normal. Further testing shows elevated 17-hydroxyprogesterone and androstenedione. Genetic analysis reveals a mutation in cytochrome b5. Which specific enzyme deficiency is functionally present in this patient?", "options": ["21-hydroxylase", "11β-hydroxylase", "17α-hydroxylase", "3β-hydroxysteroid dehydrogenase", "P450 oxidoreductase"], "answer": "E", "answer_index": 4, "explanation": "Cytochrome b5 mutations impair electron transfer to P450c17 (17,20-lyase activity), creating a combined 17α-hydroxylase/17,20-lyase deficiency pattern. This explains the elevation of 17-hydroxyprogesterone (due to impaired 17,20-lyase) alongside mineralocorticoid deficiency. The clinical picture resembles 21-hydroxylase deficiency but with a distinct steroid profile. Cytochrome b5 is a cofactor required specifically for 17,20-lyase activity of P450c17, not for the hydroxylase function.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict: The keyed answer (E, P450 oxidoreductase) is incorrect; the correct answer should be A (21-hydroxylase). The vignette describes a classic salt-wasting crisis in a 2-month-old: hyponatremia, hyperkalemia, metabolic acidosis, failure to thrive, and vomiting—hallmarks of 21-hydroxylase deficiency (21-OHD). The elevated 17-hydroxyprogesterone is the diagnostic marker for 21-OHD. While the stem mentions cytochrome b5 mutation, the rationale's explanation is medically inaccurate: cytochrome b5 deficiency impairs 17,20-lyase activity, which would reduce androgen synthesis and cause ambiguous genitalia in males or undervirilization, NOT the salt-wasting presentation described. A true cytochrome b5 deficiency would NOT produce hyperkalemia/hyponatremia (requires mineralocorticoid deficiency from impaired aldosterone synthesis). The clinical phenotype and lab findings unequivocally point to 21-hydroxylase deficiency. The item conflates two distinct entities: the stem describes 21-OHD clinically but incorrectly attributes it to cytochrome b5 mutation. P450 oxidoreductase deficiency (option E) causes a mixed picture with skeletal abnormalities (Antley-Bixler syndrome), not isolated salt-wasting. Minimal fix: Remove the cytochrome b5 reference and key to option A, or rewrite the vignette to match a true POR deficiency phenotype with skeletal findings.\", \"medical_accuracy_score\": \"2\", \"logical_validity\": false, \"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: The keyed answer (E, P450 oxidoreductase) is incorrect; the correct answer should be A (21-hydroxylase). The vignette describes a classic salt-wasting crisis in a 2-month-old: hyponatremia, hyperkalemia, metabolic acidosis, failure to thrive, and vomiting—hallmarks of 21-hydroxylase deficiency (21-OHD). The elevated 17-hydroxyprogesterone is the diagnostic marker for 21-OHD. While the stem mentions cytochrome b5 mutation, the rationale's explanation is medically inaccurate: cytochrome b5 deficiency impairs 17,20-lyase activity, which would reduce androgen synthesis and cause ambiguous genitalia in males or undervirilization, NOT the salt-wasting presentation described. A true cytochrome b5 deficiency would NOT produce hyperkalemia/hyponatremia (requires mineralocorticoid deficiency from impaired aldosterone synthesis). The clinical phenotype and lab findings unequivocally point to 21-hydroxylase deficiency. The item conflates two distinct entities: the stem describes 21-OHD clinically but incorrectly attributes it to cytochrome b5 mutation. P450 oxidoreductase deficiency (option E) causes a mixed picture with skeletal abnormalities (Antley-Bixler syndrome), not isolated salt-wasting. Minimal fix: Remove the cytochrome b5 reference and key to option A, or rewrite the vignette to match a true POR deficiency phenotype with skeletal findings.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-012", "question": "A 6-year-old boy with cystic fibrosis presents with recurrent epistaxis and digital clubbing. Chest CT shows extensive bronchiectasis with mosaic perfusion. Echocardiogram demonstrates right ventricular enlargement with an estimated pulmonary artery systolic pressure of 65 mmHg. Which specific genetic variant, when co-inherited with CFTR mutations, is most strongly associated with the development of severe pulmonary hypertension in cystic fibrosis?", "options": ["BMPR2 mutation", "ACE I/D polymorphism", "TGF-β1 codon 10 polymorphism", "Alpha-1 antitrypsin ZZ genotype", "ABCC8 mutation"], "answer": "A", "answer_index": 0, "explanation": "Co-inheritance of BMPR2 mutations, even in heterozygous state, dramatically accelerates pulmonary hypertension development in cystic fibrosis patients. While chronic hypoxia from lung disease contributes to PH, BMPR2 mutations predispose to severe vasculopathy out of proportion to lung disease severity. The other genetic variants may modify CF phenotype but do not specifically drive pulmonary hypertension development. BMPR2 mutations are the most well-established genetic risk factor for heritable pulmonary arterial hypertension.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Pediatrics", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer is not supported by established evidence. The stem describes a CF patient with severe pulmonary hypertension (PASP 65 mmHg) and asks which genetic variant co-inherited with CFTR mutations is \\\"most strongly associated\\\" with severe PH development in CF. Key stem clues: CF diagnosis, severe PH, bronchiectasis with mosaic perfusion, RV enlargement. The keyed answer (A: BMPR2 mutation) is problematic because: (1) BMPR2 mutations cause heritable pulmonary arterial hypertension (PAH), not the secondary PH typically seen in CF lung disease; (2) there is no robust published evidence that BMPR2 mutations are \\\"most strongly associated\\\" with PH specifically in CF patients as a modifier gene; (3) the rationale conflates heritable PAH pathophysiology with CF-related PH. The ACE I/D polymorphism (B) has some literature support as a CF modifier affecting pulmonary outcomes, though evidence is mixed. Medical accuracy issue: The item presents BMPR2 as an established CF-PH modifier gene without supporting evidence; this teaching point appears fabricated. The question requires specialized knowledge of CF genetic modifiers that may not exist in mainstream literature. Minimal fix: Replace with a validated CF modifier gene question (e.g., MBL2, TGFB1 for general CF severity) or reframe as a general heritable PAH genetics question without the CF context.\", \"medical_accuracy_score\": \"2\", \"logical_validity\": false, \"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer is not supported by established evidence. The stem describes a CF patient with severe pulmonary hypertension (PASP 65 mmHg) and asks which genetic variant co-inherited with CFTR mutations is \"most strongly associated\" with severe PH development in CF. Key stem clues: CF diagnosis, severe PH, bronchiectasis with mosaic perfusion, RV enlargement. The keyed answer (A: BMPR2 mutation) is problematic because: (1) BMPR2 mutations cause heritable pulmonary arterial hypertension (PAH), not the secondary PH typically seen in CF lung disease; (2) there is no robust published evidence that BMPR2 mutations are \"most strongly associated\" with PH specifically in CF patients as a modifier gene; (3) the rationale conflates heritable PAH pathophysiology with CF-related PH. The ACE I/D polymorphism (B) has some literature support as a CF modifier affecting pulmonary outcomes, though evidence is mixed. Medical accuracy issue: The item presents BMPR2 as an established CF-PH modifier gene without supporting evidence; this teaching point appears fabricated. The question requires specialized knowledge of CF genetic modifiers that may not exist in mainstream literature. Minimal fix: Replace with a validated CF modifier gene question (e.g., MBL2, TGFB1 for general CF severity) or reframe as a general heritable PAH genetics question without the CF context.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-013", "question": "A 19-year-old college athlete collapses during basketball practice. Initial rhythm shows pulseless electrical activity. Return of spontaneous circulation occurs after 15 minutes of CPR. ECG shows diffuse ST-segment elevations in precordial leads. Bedside echocardiogram shows severely reduced left ventricular function with apical akinesis. Troponin I is markedly elevated at 50 ng/mL. Coronary angiography is normal. Which specific test result would confirm the most likely diagnosis?", "options": ["Genetic testing for lamin A/C mutation", "Serum catecholamine levels", "Right ventricular endomyocardial biopsy", "Cardiac MRI with gadolinium enhancement", "Plasma metanephrines"], "answer": "D", "answer_index": 3, "explanation": "This describes commotio cordis with subsequent stress-induced (takotsubo) cardiomyopathy. Cardiac MRI would show characteristic apical ballooning with edema on T2-weighted imaging and absence of late gadolinium enhancement, distinguishing it from myocardial infarction. Endomyocardial biopsy is invasive and nonspecific. Genetic testing would be for inherited cardiomyopathies which present differently. Catecholamine levels may be elevated but are not diagnostic. Commotio cordis can trigger neurogenic stunning through direct chest impact.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The vignette describes a young athlete with sudden cardiac arrest, diffuse ST elevations, apical akinesis, elevated troponin, and normal coronaries—a pattern consistent with multiple diagnoses. The author's rationale invokes \\\"commotio cordis with subsequent takotsubo\\\" but commotio cordis typically causes ventricular fibrillation from direct chest impact (not mentioned in stem), not PEA, and resolves without the prolonged dysfunction described here. The clinical picture better fits acute myocarditis (viral or other), which would show late gadolinium enhancement on cardiac MRI (option D) AND could be confirmed by endomyocardial biopsy (option C). Both tests are standard diagnostic modalities for myocarditis per AHA/ACC guidelines. The stem lacks critical discriminating details: (1) no mention of chest impact to support commotio cordis, (2) no timeline to distinguish takotsubo from myocarditis, (3) both D and C are defensible as \\\"confirmatory\\\" tests. The keyed answer (D) is reasonable but not uniquely best without excluding C. Medical accuracy issues: the rationale conflates distinct entities and mischaracterizes commotio cordis pathophysiology. Minimal fix: Add \\\"witnessed precordial impact\\\" and specify \\\"non-invasive confirmatory test\\\" to uniquely support D, or clarify clinical timeline favoring takotsubo over myocarditis.\", \"medical_accuracy_score\": \"3\", \"logical_validity\": false, \"logical_false_reason\": \"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The vignette describes a young athlete with sudden cardiac arrest, diffuse ST elevations, apical akinesis, elevated troponin, and normal coronaries—a pattern consistent with multiple diagnoses. The author's rationale invokes \"commotio cordis with subsequent takotsubo\" but commotio cordis typically causes ventricular fibrillation from direct chest impact (not mentioned in stem), not PEA, and resolves without the prolonged dysfunction described here. The clinical picture better fits acute myocarditis (viral or other), which would show late gadolinium enhancement on cardiac MRI (option D) AND could be confirmed by endomyocardial biopsy (option C). Both tests are standard diagnostic modalities for myocarditis per AHA/ACC guidelines. The stem lacks critical discriminating details: (1) no mention of chest impact to support commotio cordis, (2) no timeline to distinguish takotsubo from myocarditis, (3) both D and C are defensible as \"confirmatory\" tests. The keyed answer (D) is reasonable but not uniquely best without excluding C. Medical accuracy issues: the rationale conflates distinct entities and mischaracterizes commotio cordis pathophysiology. Minimal fix: Add \"witnessed precordial impact\" and specify \"non-invasive confirmatory test\" to uniquely support D, or clarify clinical timeline favoring takotsubo over myocarditis.", "medical_accuracy_score": 3, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 3}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-014", "question": "A 57-year-old man presents with 2 days of progressive weakness, dysarthria, and ophthalmoplegia. He recently returned from a fishing trip where he consumed self-caught shellfish. Examination shows descending flaccid paralysis with preserved sensation. Electromyography demonstrates presynaptic neuromuscular blockade. Which specific antagonist administration provides the most definitive diagnostic confirmation?", "options": ["Atropine for muscarinic receptors", "Edrophonium for acetylcholinesterase", "4-aminopyridine for potassium channels", "Guanidine for calcium channels", "Physostigmine for blood-brain barrier penetration"], "answer": "B", "answer_index": 1, "explanation": "This describes botulism from shellfish toxicity. Edrophonium (Tensilon test) may transiently improve weakness in botulism by increasing acetylcholine availability, though the response is less dramatic than in myasthenia gravis. The key is the presynaptic blockade at the neuromuscular junction. Atropine would worsen symptoms by further inhibiting parasympathetic function. 4-aminopyridine helps in Lambert-Eaton syndrome. Guanidine is no longer used. Physostigmine crosses the blood-brain barrier but isn't specific for diagnosis.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer is not the best answer. Key stem clues: descending flaccid paralysis, shellfish consumption, ophthalmoplegia, dysarthria, presynaptic neuromuscular blockade on EMG - all classic for botulism. The question asks for \\\"most definitive diagnostic confirmation.\\\" Medical accuracy issue: Edrophonium (choice B, the key) is NOT used for botulism diagnosis. The Tensilon test is specific for myasthenia gravis (postsynaptic disorder), not botulism (presynaptic). In botulism, edrophonium typically shows minimal or no response because the problem is inadequate ACh release, not receptor blockade. The author's rationale acknowledges \\\"response is less dramatic than in myasthenia gravis,\\\" which undermines its diagnostic utility. None of the listed options represent actual botulism diagnostic tests (mouse bioassay, toxin detection). However, if forced to choose among these options, 4-aminopyridine (C) would be more logical as it enhances presynaptic ACh release by blocking K+ channels and has been studied in botulism, though it's primarily associated with Lambert-Eaton. The item conflates diagnostic approaches for different neuromuscular disorders. Minimal fix: Replace options with actual botulism diagnostics (toxin assay, mouse bioassay) or reframe question to ask about symptomatic treatment rather than diagnostic confirmation.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer is not the best answer. Key stem clues: descending flaccid paralysis, shellfish consumption, ophthalmoplegia, dysarthria, presynaptic neuromuscular blockade on EMG - all classic for botulism. The question asks for \"most definitive diagnostic confirmation.\" Medical accuracy issue: Edrophonium (choice B, the key) is NOT used for botulism diagnosis. The Tensilon test is specific for myasthenia gravis (postsynaptic disorder), not botulism (presynaptic). In botulism, edrophonium typically shows minimal or no response because the problem is inadequate ACh release, not receptor blockade. The author's rationale acknowledges \"response is less dramatic than in myasthenia gravis,\" which undermines its diagnostic utility. None of the listed options represent actual botulism diagnostic tests (mouse bioassay, toxin detection). However, if forced to choose among these options, 4-aminopyridine (C) would be more logical as it enhances presynaptic ACh release by blocking K+ channels and has been studied in botulism, though it's primarily associated with Lambert-Eaton. The item conflates diagnostic approaches for different neuromuscular disorders. Minimal fix: Replace options with actual botulism diagnostics (toxin assay, mouse bioassay) or reframe question to ask about symptomatic treatment rather than diagnostic confirmation.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-015", "question": "A 34-year-old woman presents with altered mental status following a party where she used 'bath salts.' She is tachycardic, hypertensive, and hyperthermic (40.1°C). Laboratory studies show metabolic acidosis with pH 7.18 and creatinine kinase of 25,000 U/L. Urine drug screen is positive for amphetamines. Despite aggressive cooling and benzodiazepines, she develops rigid-body paralysis with fixed, dilated pupils. Which specific toxin is most likely responsible for this neurological deterioration?", "options": ["Mephedrone-induced serotonin syndrome", "Methylone causing malignant hyperthermia", "MDPV (methylenedioxypyrovalerone) inducing neuroleptic malignant syndrome", "Butylone resulting in sympathomimetic toxidrome", "Alpha-PVP provoking excited delirium"], "answer": "C", "answer_index": 2, "explanation": "MDPV is a potent dopamine-norepinephrine reuptake inhibitor found in bath salts that can cause a syndrome indistinguishable from neuroleptic malignant syndrome, with rigidity, hyperthermia, and autonomic instability. The fixed, dilated pupils and rigid-body paralysis after initial agitation suggest transition to a malignant catatonic state. This differs from serotonin syndrome which features clonus rather than rigidity. Malignant hyperthermia is triggered by inhalational agents, not street drugs. The pattern reflects profound dopaminergic dysregulation.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Emergency Medicine", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes a patient with synthetic cathinone toxicity presenting with hyperthermia, rigidity, autonomic instability, and rhabdomyolysis. Key discriminating findings include rigid-body paralysis, fixed dilated pupils, and failure to respond to standard treatment. The rationale claims MDPV causes NMS-like syndrome, but this is medically problematic. True NMS requires antipsychotic exposure; synthetic cathinones cause severe sympathomimetic toxicity that can present with rigidity but is not NMS. The distinction between options A (serotonin syndrome), C (claimed NMS), and E (excited delirium) becomes arbitrary because: (1) multiple bath salt components can cause similar presentations, (2) serotonin syndrome can present with rigidity in severe cases despite the rationale's claim of only clonus, (3) excited delirium describes the same clinical picture, and (4) the specific toxin cannot be determined from clinical features alone as these synthetic cathinones produce overlapping toxidromes. Medical accuracy issues: misapplication of NMS terminology to non-antipsychotic drugs, oversimplified distinction between syndromes. Minimal fix: Either specify which bath salt component was confirmed by toxicology, or reframe as asking for the toxidrome/syndrome rather than the specific chemical, acknowledging clinical overlap.\",\"medical_accuracy_score\":\"2\",\"logical_validity\":false,\"logical_false_reason\":\"M\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: M (Multiple answers defensible). Verdict: Not uniquely determinable. The stem describes a patient with synthetic cathinone toxicity presenting with hyperthermia, rigidity, autonomic instability, and rhabdomyolysis. Key discriminating findings include rigid-body paralysis, fixed dilated pupils, and failure to respond to standard treatment. The rationale claims MDPV causes NMS-like syndrome, but this is medically problematic. True NMS requires antipsychotic exposure; synthetic cathinones cause severe sympathomimetic toxicity that can present with rigidity but is not NMS. The distinction between options A (serotonin syndrome), C (claimed NMS), and E (excited delirium) becomes arbitrary because: (1) multiple bath salt components can cause similar presentations, (2) serotonin syndrome can present with rigidity in severe cases despite the rationale's claim of only clonus, (3) excited delirium describes the same clinical picture, and (4) the specific toxin cannot be determined from clinical features alone as these synthetic cathinones produce overlapping toxidromes. Medical accuracy issues: misapplication of NMS terminology to non-antipsychotic drugs, oversimplified distinction between syndromes. Minimal fix: Either specify which bath salt component was confirmed by toxicology, or reframe as asking for the toxidrome/syndrome rather than the specific chemical, acknowledging clinical overlap.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "M", "verdict": "FAIL", "fail_reason": "M"}, "judge_verdict": "FAIL", "judge_fail_reason": "M", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-016", "question": "A 29-year-old G3P2 at 34 weeks presents with acute shortness of breath and pleuritic chest pain. CT pulmonary angiography shows multiple segmental pulmonary emboli. She is started on therapeutic enoxaparin. 48 hours later, she develops severe abdominal pain, hypotension, and a rapidly enlarging uterine fundus. Ultrasound shows a large retroplacental hematoma with fetal bradycardia. Emergency cesarean delivery is performed. Pathology examination of the placenta would most likely reveal which specific finding?", "options": ["Extensive perivillous fibrin deposition", "Acute atherosis of spiral arteries", "Massive intervillous thrombosis", "Placental site giant cells with fibrinoid necrosis", "Basal plate myometrial fibers"], "answer": "C", "answer_index": 2, "explanation": "This describes heparin-induced thrombocytopenia (HIT) with thrombosis causing both pulmonary embolism and placental thrombosis/abruption. Massive intervillous thrombosis is characteristic of hypercoagulable states and would explain the acute abruption. HIT typically presents 5-10 days after heparin initiation but can occur rapidly if there has been recent heparin exposure. Acute atherosis is seen in preeclampsia, not thrombotic disorders. Perivillous fibrin deposition is chronic, not acute. The timing suggests HIT rather than underlying thrombophilia.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Obstetrics and Gynecology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer does not match the clinical scenario. Key stem clues: 29-year-old pregnant woman at 34 weeks with PE treated with enoxaparin, develops acute abruption 48 hours later with retroplacental hematoma. The clinical presentation describes placental abruption (retroplacental hematoma, severe abdominal pain, hypotension, enlarging fundus, fetal bradycardia). Placental abruption is characterized by hemorrhage between the placenta and uterine wall, NOT intervillous thrombosis. Massive intervillous thrombosis (option C) is a distinct pathologic entity involving thrombosis within the intervillous space of the placenta, typically associated with chronic hypercoagulable states and recurrent pregnancy loss, not acute abruption. The correct pathologic finding in acute abruption would be retroplacental hemorrhage/hematoma with basal plate separation. Option E (basal plate myometrial fibers) represents placenta accreta spectrum, which could cause acute hemorrhage but doesn't match the retroplacental location. The author's rationale conflates HIT-induced abruption with intervillous thrombosis - these are distinct pathologic entities. Main medical issue: confusion between clinical abruption and the specific pathologic finding of intervillous thrombosis. Minimal fix: Change key to match actual abruption pathology or rewrite vignette to describe chronic placental insufficiency rather than acute abruption.\", \"medical_accuracy_score\": \"2\", \"logical_validity\": false, \"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer does not match the clinical scenario. Key stem clues: 29-year-old pregnant woman at 34 weeks with PE treated with enoxaparin, develops acute abruption 48 hours later with retroplacental hematoma. The clinical presentation describes placental abruption (retroplacental hematoma, severe abdominal pain, hypotension, enlarging fundus, fetal bradycardia). Placental abruption is characterized by hemorrhage between the placenta and uterine wall, NOT intervillous thrombosis. Massive intervillous thrombosis (option C) is a distinct pathologic entity involving thrombosis within the intervillous space of the placenta, typically associated with chronic hypercoagulable states and recurrent pregnancy loss, not acute abruption. The correct pathologic finding in acute abruption would be retroplacental hemorrhage/hematoma with basal plate separation. Option E (basal plate myometrial fibers) represents placenta accreta spectrum, which could cause acute hemorrhage but doesn't match the retroplacental location. The author's rationale conflates HIT-induced abruption with intervillous thrombosis - these are distinct pathologic entities. Main medical issue: confusion between clinical abruption and the specific pathologic finding of intervillous thrombosis. Minimal fix: Change key to match actual abruption pathology or rewrite vignette to describe chronic placental insufficiency rather than acute abruption.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-017", "question": "A 68-year-old man with severe aortic stenosis presents for transcatheter aortic valve replacement under general anesthesia. Shortly after valve deployment, the blood pressure drops from 130/80 to 60/30 mmHg. Transesophageal echocardiography shows new severe mitral regurgitation with a flail posterior leaflet. The left ventricle is hyperdynamic. Which specific maneuver would most likely improve the hemodynamics temporarily?", "options": ["Increase tidal volume to 10 mL/kg", "Administer phenylephrine bolus", "Initiate intra-aortic balloon pump", "Increase inhaled anesthetic concentration", "Admin intravenous fluid bolus"], "answer": "B", "answer_index": 1, "explanation": "In acute severe mitral regurgitation with afterload reduction (from the new valve), increasing afterload with phenylephrine can improve forward flow by reducing the regurgitant fraction. This differs from chronic MR where afterload reduction is beneficial. Fluid administration would worsen pulmonary edema. Increasing anesthetic depth would further depress hemodynamics. An intra-aortic balloon pump is contraindicated in aortic insufficiency, which may occur after TAVR. The hyperdynamic LV suggests adequate preload but excessive afterload mismatch.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer is incorrect. Key stem clues: acute severe MR with flail leaflet post-TAVR, hypotension (60/30), hyperdynamic LV. The clinical problem is cardiogenic shock from acute severe MR causing reduced forward cardiac output. The keyed answer (phenylephrine) is medically incorrect. In acute severe MR, increasing afterload with vasopressors worsens the regurgitant fraction by increasing impedance to forward flow, forcing more blood retrograde into the LA. The hyperdynamic LV indicates the ventricle is contracting vigorously but ejecting into two outlets (aorta and LA); raising SVR preferentially increases regurgitation. The correct answer is C (IABP). IABP reduces afterload during systole (decreasing MR) and augments diastolic pressure (improving coronary perfusion), making it the standard temporary mechanical support for acute severe MR with hemodynamic collapse. The rationale's claim that IABP is contraindicated due to possible AI post-TAVR is unfounded - mild paravalvular leak does not preclude IABP, and severe AI requiring IABP contraindication would be mentioned explicitly. The rationale confuses acute vs chronic MR management principles. Minimal fix: Change key to C or rewrite vignette to specify contraindication to IABP.\", \"medical_accuracy_score\": \"2\", \"logical_validity\": false, \"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer is incorrect. Key stem clues: acute severe MR with flail leaflet post-TAVR, hypotension (60/30), hyperdynamic LV. The clinical problem is cardiogenic shock from acute severe MR causing reduced forward cardiac output. The keyed answer (phenylephrine) is medically incorrect. In acute severe MR, increasing afterload with vasopressors worsens the regurgitant fraction by increasing impedance to forward flow, forcing more blood retrograde into the LA. The hyperdynamic LV indicates the ventricle is contracting vigorously but ejecting into two outlets (aorta and LA); raising SVR preferentially increases regurgitation. The correct answer is C (IABP). IABP reduces afterload during systole (decreasing MR) and augments diastolic pressure (improving coronary perfusion), making it the standard temporary mechanical support for acute severe MR with hemodynamic collapse. The rationale's claim that IABP is contraindicated due to possible AI post-TAVR is unfounded - mild paravalvular leak does not preclude IABP, and severe AI requiring IABP contraindication would be mentioned explicitly. The rationale confuses acute vs chronic MR management principles. Minimal fix: Change key to C or rewrite vignette to specify contraindication to IABP.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-018", "question": "A 52-year-old woman with rheumatoid arthritis on adalimumab presents for lumbar fusion surgery. During prone positioning with Jackson table, motor-evoked potentials from the lower extremities are lost. Mean arterial pressure is 65 mmHg. Which specific anesthetic intervention is most likely to restore neuromonitoring signals?", "options": ["Increase sevoflurane concentration to 1.2 MAC", "Administer ketamine 0.5 mg/kg IV", "Increase remifentanil infusion rate", "Administer phenylephrine to MAP 90 mmHg", "Decrease propofol infusion by 50%"], "answer": "D", "answer_index": 3, "explanation": "In prone positioning, spinal cord perfusion is critically dependent on mean arterial pressure due to increased intra-abdominal/venous pressure. For patients with spinal stenosis or compromised blood flow, MAP targets of 85-90 mmHg are often needed to maintain adequate spinal cord perfusion. While propofol and inhalational agents suppress MEPs, the acute loss suggests ischemia rather than anesthetic depth. Ketamine may help but addresses different mechanisms. The key is optimizing perfusion pressure specific to the prone position.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Anesthesiology", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\":\"Validity label: V. Verdict: Correct best answer. The vignette describes acute loss of motor-evoked potentials (MEPs) during prone positioning for spinal surgery with MAP 65 mmHg. Key discriminating findings: (1) prone positioning increases intra-abdominal/venous pressure, reducing spinal cord perfusion pressure; (2) acute MEP loss during positioning suggests ischemic etiology rather than anesthetic depth; (3) baseline MAP 65 mmHg is suboptimal for spinal cord perfusion in prone position. The question asks for the intervention most likely to restore signals. Option D (phenylephrine to MAP 90 mmHg) directly addresses spinal cord hypoperfusion, the most likely cause given the temporal relationship to positioning. Options A and C would worsen MEP suppression (sevoflurane and opioids suppress MEPs). Option E (decrease propofol) might help but is less directly targeted than augmenting perfusion pressure. Option B (ketamine) can enhance MEPs but doesn't address the primary ischemic mechanism. The keyed answer is medically sound: prone positioning compromises venous drainage and requires higher MAP targets (85-90 mmHg) to maintain spinal cord perfusion. No logical flaws or missing critical details prevent unique best-answer selection. Minimal fix: None needed; item is valid and accurate.\",\"medical_accuracy_score\":\"5\",\"logical_validity\":true,\"logical_false_reason\":\"T\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: V. Verdict: Correct best answer. The vignette describes acute loss of motor-evoked potentials (MEPs) during prone positioning for spinal surgery with MAP 65 mmHg. Key discriminating findings: (1) prone positioning increases intra-abdominal/venous pressure, reducing spinal cord perfusion pressure; (2) acute MEP loss during positioning suggests ischemic etiology rather than anesthetic depth; (3) baseline MAP 65 mmHg is suboptimal for spinal cord perfusion in prone position. The question asks for the intervention most likely to restore signals. Option D (phenylephrine to MAP 90 mmHg) directly addresses spinal cord hypoperfusion, the most likely cause given the temporal relationship to positioning. Options A and C would worsen MEP suppression (sevoflurane and opioids suppress MEPs). Option E (decrease propofol) might help but is less directly targeted than augmenting perfusion pressure. Option B (ketamine) can enhance MEPs but doesn't address the primary ischemic mechanism. The keyed answer is medically sound: prone positioning compromises venous drainage and requires higher MAP targets (85-90 mmHg) to maintain spinal cord perfusion. No logical flaws or missing critical details prevent unique best-answer selection. Minimal fix: None needed; item is valid and accurate.", "medical_accuracy_score": 5, "logical_validity": true, "logical_false_reason": "T", "verdict": "PASS", "fail_reason": "NA"}, "judge_verdict": "PASS", "judge_fail_reason": "NA", "judge_medical_accuracy_score": 5}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-019", "question": "A 40-year-old man with schizophrenia stable on clozapine develops fever, confusion, and muscle rigidity. Creatinine kinase is elevated at 3,500 U/L. Clozapine is discontinued, and he is treated for neuroleptic malignant syndrome. One week later, he develops profuse diarrhea with abdominal cramping. Stool studies are positive for Clostridium difficile toxin. Which specific immunologic mechanism explains this sequence of events?", "options": ["Clozapine-induced agranulocytosis predisposing to infection", "Anticholinergic effects causing toxic megacolon", "NMS-associated immunoparlysis facilitating C. difficile overgrowth", "Increased intestinal permeability from muscle breakdown", "Clozapine discontinuation causing rebound cholinergic surge"], "answer": "C", "answer_index": 2, "explanation": "NMS induces a systemic inflammatory state followed by immunoparlysis (similar to sepsis), impairing neutrophil function and predisposing to opportunistic infections like C. difficile. This is distinct from clozapine's known agranulocytosis risk. The timing after NMS resolution suggests immunoparlysis rather than direct drug effect. Rebound cholinergic effects from antipsychotic withdrawal are theoretical but not established. The sequence reflects the biphasic immune response in severe systemic inflammatory states.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed - option A is the best defensible answer. The stem describes a patient on clozapine who develops NMS, then C. difficile infection one week later. Key discriminating findings: (1) patient on clozapine (known agranulocytosis risk requiring monitoring), (2) develops NMS requiring clozapine discontinuation, (3) subsequent C. difficile infection. The keyed answer (C) invokes 'NMS-associated immunoparlysis' as the mechanism. However, this concept lacks established medical evidence. NMS is a neuromuscular emergency with autonomic instability, not a condition recognized to cause clinically significant immunosuppression or 'immunoparlysis' predisposing to opportunistic infections. The rationale incorrectly analogizes NMS to sepsis without supporting evidence. Option A (clozapine-induced agranulocytosis) is the well-established, board-relevant mechanism: clozapine carries a 0.8-2% risk of agranulocytosis, requires mandatory WBC monitoring, and neutropenia directly predisposes to bacterial infections including C. difficile. The timing (one week post-NMS) is consistent with either pre-existing neutropenia or its delayed infectious complications. The item conflates a theoretical immunologic concept with established pharmacology. Minimal fix: Change key to A, or rewrite stem to explicitly exclude agranulocytosis (e.g., 'normal WBC throughout') and provide evidence supporting NMS-related immunosuppression.\", \"medical_accuracy_score\": \"2\", \"logical_validity\": false, \"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed - option A is the best defensible answer. The stem describes a patient on clozapine who develops NMS, then C. difficile infection one week later. Key discriminating findings: (1) patient on clozapine (known agranulocytosis risk requiring monitoring), (2) develops NMS requiring clozapine discontinuation, (3) subsequent C. difficile infection. The keyed answer (C) invokes 'NMS-associated immunoparlysis' as the mechanism. However, this concept lacks established medical evidence. NMS is a neuromuscular emergency with autonomic instability, not a condition recognized to cause clinically significant immunosuppression or 'immunoparlysis' predisposing to opportunistic infections. The rationale incorrectly analogizes NMS to sepsis without supporting evidence. Option A (clozapine-induced agranulocytosis) is the well-established, board-relevant mechanism: clozapine carries a 0.8-2% risk of agranulocytosis, requires mandatory WBC monitoring, and neutropenia directly predisposes to bacterial infections including C. difficile. The timing (one week post-NMS) is consistent with either pre-existing neutropenia or its delayed infectious complications. The item conflates a theoretical immunologic concept with established pharmacology. Minimal fix: Change key to A, or rewrite stem to explicitly exclude agranulocytosis (e.g., 'normal WBC throughout') and provide evidence supporting NMS-related immunosuppression.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}, {"quiz_id": "20251216T183904770Z_deepseek-v3.2_seed128", "question_id": "20251216T183904770Z_deepseek-v3.2_seed128-020", "question": "A 65-year-old woman with treatment-resistant depression receives ketamine infusion therapy. During the infusion, she experiences dissociative symptoms but shows marked mood improvement. However, 48 hours later, she develops severe agitation, paranoid ideation, and visual hallucinations. MRI brain shows new, symmetric T2 hyperintensities in the splenium of the corpus callosum. Which specific pathogenetic mechanism explains this delayed neurological complication?", "options": ["Ketamine-induced excitotoxicity via NMDA receptor internalization", "Unmasking of underlying neurodegenerative disease", "Osmotic demyelination from rapid mood improvement", "Autoimmune encephalitis triggered by glutamatergic activation", "Cerebral hyperperfusion from nitric oxide-mediated vasodilation"], "answer": "A", "answer_index": 0, "explanation": "This describes delayed neurotoxicity from ketamine, possibly via downstream effects of NMDA receptor antagonism including compensatory glutamate surge and excitotoxicity. The splenial lesion is characteristic of transient lesion syndrome associated with various toxins and seizures. This differs from osmotic demyelination which affects pons more commonly. Autoimmune encephalitis would present differently. The timing suggests a metabolic/toxic mechanism rather than unmasking of underlying disease. Ketamine's effects on glutamate homeostasis can cause both therapeutic and adverse neurological effects.", "generator_model": "deepseek-v3.2", "seed": 128, "category": "medicine", "difficulty": "very-hard", "not_for_clinical_use": true, "target_topic": "Psychiatry", "judge_model": "claude-opus-4-5-20251101", "judge_model_outputs_raw": "{\"analysis\": \"Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer is not the best answer. Key stem clues: 65-year-old woman, ketamine infusion, delayed presentation (48 hours), new symmetric T2 hyperintensities in splenium of corpus callosum. The clinical picture describes cytotoxic lesion of the corpus callosum (CLOCC)/reversible splenial lesion syndrome (RESLES). Main logical issue: Option A (ketamine-induced excitotoxicity via NMDA receptor internalization) is mechanistically incorrect. NMDA receptor antagonism by ketamine blocks receptors; it does not cause receptor internalization as a primary mechanism. The rationale mentions 'compensatory glutamate surge' but this is not what option A states. The splenial lesion pattern is indeed associated with various toxic-metabolic insults, but the specific mechanism listed in A is inaccurate. Options B-E are clearly incorrect (osmotic demyelination affects pons, autoimmune encephalitis has different presentation, hyperperfusion doesn't explain this pattern, no evidence of neurodegenerative disease). Main medical accuracy issue: The mechanism in option A conflates NMDA antagonism with receptor internalization, which are distinct processes. Minimal fix: Rewrite option A to accurately reflect glutamatergic dysregulation or excitotoxicity from NMDA antagonism without the incorrect 'internalization' mechanism, or provide an option describing metabolic/toxic cytotoxic edema more accurately.\", \"medical_accuracy_score\": \"2\", \"logical_validity\": false, \"logical_false_reason\": \"K\"}", "judge_output_valid": true, "judge_parse_error": null, "judge_json": {"analysis": "Validity label: K (Miskeyed). Verdict: Miskeyed - the keyed answer is not the best answer. Key stem clues: 65-year-old woman, ketamine infusion, delayed presentation (48 hours), new symmetric T2 hyperintensities in splenium of corpus callosum. The clinical picture describes cytotoxic lesion of the corpus callosum (CLOCC)/reversible splenial lesion syndrome (RESLES). Main logical issue: Option A (ketamine-induced excitotoxicity via NMDA receptor internalization) is mechanistically incorrect. NMDA receptor antagonism by ketamine blocks receptors; it does not cause receptor internalization as a primary mechanism. The rationale mentions 'compensatory glutamate surge' but this is not what option A states. The splenial lesion pattern is indeed associated with various toxic-metabolic insults, but the specific mechanism listed in A is inaccurate. Options B-E are clearly incorrect (osmotic demyelination affects pons, autoimmune encephalitis has different presentation, hyperperfusion doesn't explain this pattern, no evidence of neurodegenerative disease). Main medical accuracy issue: The mechanism in option A conflates NMDA antagonism with receptor internalization, which are distinct processes. Minimal fix: Rewrite option A to accurately reflect glutamatergic dysregulation or excitotoxicity from NMDA antagonism without the incorrect 'internalization' mechanism, or provide an option describing metabolic/toxic cytotoxic edema more accurately.", "medical_accuracy_score": 2, "logical_validity": false, "logical_false_reason": "K", "verdict": "FAIL", "fail_reason": "K"}, "judge_verdict": "FAIL", "judge_fail_reason": "K", "judge_medical_accuracy_score": 2}]